STOCK TITAN

22Nd Century Stock Price, News & Analysis

XXII Nasdaq

Welcome to our dedicated page for 22Nd Century news (Ticker: XXII), a resource for investors and traders seeking the latest updates and insights on 22Nd Century stock.

22nd Century Group (NASDAQ: XXII) pioneers plant-based solutions for tobacco harm reduction through advanced biotechnology. This news hub provides investors and stakeholders with essential updates on regulatory milestones, product innovations, and operational developments central to the company's mission of reducing nicotine addiction.

Access authoritative coverage of FDA communications, VLN product advancements, and manufacturing capacity updates. Our curated collection includes earnings reports, patent filings, and scientific research collaborations that demonstrate 22nd Century's leadership in developing reduced-nicotine tobacco products.

Key updates feature the company's Modified Risk Tobacco Product authorization, progress in international market expansion, and innovations in nicotine biosynthesis control. Regular updates ensure informed tracking of this biotechnology firm's unique position at the intersection of public health and commercial tobacco production.

Bookmark this page for streamlined access to verified corporate announcements and analysis-free reporting on 22nd Century's progress in redefining tobacco consumption through science-driven solutions.

Rhea-AI Summary

22nd Century Group (Nasdaq: XXII) reported Q2 2025 financial results, showing a revenue decline to $4.1 million from $6.0 million in Q1 2025. The company reported a net loss of $3.3 million and an Adjusted EBITDA loss of $2.6 million.

Key developments include expanded state authorizations for VLN® products (now in 44 states), partnership with Pinnacle for VLN® distribution in nearly 1,000 locations of a top-5 c-store chain, and debt reduction of $1.0 million to $3.8 million. The company's cigarette volumes increased to 594,000 cartons in Q2 2025 compared to 319,000 in Q1 2025.

The company is advancing its tobacco harm reduction strategy with its proprietary reduced nicotine content tobacco products, including development of a 100mm VLN® cigarette prototype targeting FDA submission in Q4 2025.

[ "Expanded state authorizations to 44 states for VLN® products", "Secured partnership with Pinnacle VLN® for distribution in nearly 1,000 top-5 c-store locations", "Increased cigarette carton volumes by 86% quarter-over-quarter to 594,000", "Reduced debt by $1.0 million to $3.8 million", "Advanced development of 100mm VLN® reduced nicotine cigarette prototype" ]
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.11%
Tags
-
Rhea-AI Summary

22nd Century Group (Nasdaq: XXII) has scheduled its Second Quarter 2025 earnings conference call for August 14, 2025, at 8:00 AM ET. The company will release its financial results via press release at 6:00 AM ET the same day.

CEO Larry Firestone and CFO Dan Otto will lead the webcast, discussing quarterly results, recent developments, and outlook for 2025. The webcast will be available live and archived on the company's investor relations website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.4%
Tags
-
Rhea-AI Summary

22nd Century Group (Nasdaq: XXII) announced the initial shipments of its Pinnacle VLN® Gold and Pinnacle VLN® Menthol reduced nicotine cigarettes. The products will launch on September 1, 2025 across nearly 1,000 locations in 12 states through a top-5 U.S. convenience store chain.

The Pinnacle VLN® cigarettes contain 95% less nicotine compared to traditional cigarettes, meeting the FDA's proposed standard of less than 0.7 mg/g nicotine content. These products are the first and only FDA-authorized combusted cigarettes specifically designed to reduce nicotine intake, supported by extensive clinical research demonstrating their effectiveness in reducing smoking habits.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.4%
Tags
none
Rhea-AI Summary

22nd Century Group (Nasdaq: XXII) welcomes the American Academy of Family Physicians' (AAFP) support for the FDA's proposed reduced nicotine mandate. The AAFP, representing over 128,300 family physicians, endorses establishing a maximum nicotine yield of 0.7 milligrams per gram of tobacco in combustible products.

The company's VLN® products, including partner brands Smoker Friendly VLN® and Pinnacle VLN®, are currently the only FDA-authorized reduced nicotine content cigarettes that comply with the proposed standard. According to the release, smoking causes over 480,000 deaths and costs more than $600 billion annually in the United States, while reducing life expectancy by 10 years.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.41%
Tags
-
Rhea-AI Summary

22nd Century Group (Nasdaq: XXII) announced significant progress in state authorizations for its tobacco product portfolio. The company has secured approval to sell its VLN® reduced nicotine content cigarettes in up to 41 states, along with expanded authorizations for partner brands and conventional products.

The company's flagship VLN® products contain 95% less nicotine than conventional cigarettes and are the only combustible cigarettes that comply with the FDA's proposed Low Nicotine Mandate. 22nd Century has secured partnerships with retailers representing over 2,000 outlets for implementation in the second half of 2025.

The expanded state authorizations cover multiple product lines including VLN® Gold and Green (41 states), VLN® Red (21 states), Smoker Friendly VLN® (20 states), Pinnacle® VLN® (20 states), and various conventional products across different states.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.99%
Tags
none
-
Rhea-AI Summary

22nd Century Group (Nasdaq: XXII) is gaining traction with its VLN® reduced nicotine content cigarettes as multiple tobacco brands partner to expand product availability. The company's proprietary tobacco contains 95% less nicotine than conventional cigarettes, meeting the FDA's proposed standard of 0.7 mg nicotine per gram of tobacco.

The FDA's January 2025 proposed Tobacco Product Standard aims to reduce smoking-related harm by limiting nicotine content in cigarettes. VLN® products, averaging 0.5 mg per gram, are currently the only FDA-authorized combustible cigarettes meeting this standard. The FDA projects this initiative could prevent approximately 48 million youth and young adults from starting smoking by 2100.

New partnerships including Smoker Friendly VLN® and Pinnacle VLN® demonstrate growing industry adoption ahead of the standard's implementation, expected two years after final approval.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.58%
Tags
Rhea-AI Summary

22nd Century Group (Nasdaq: XXII) provided an update on the Modified Risk Tobacco Product (MRTP) renewal process for its VLN® reduced nicotine content products. VLN® is the first and only FDA-authorized combustible cigarette containing 95% less nicotine than conventional cigarettes, with renewal due in December 2026.

The company's VLN® products, originally authorized in December 2021, have demonstrated through extensive clinical research their ability to reduce smoking rates, increase quit attempts, and lower nicotine consumption. The product line is expanding with more brands using VLN® tobacco, meeting FDA's proposed low nicotine mandate issued in January 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.11%
Tags
-
Rhea-AI Summary

22nd Century Group (Nasdaq: XXII) has announced "Operation 100," an initiative to develop a 100mm version of their VLN® reduced nicotine content cigarettes. The company plans to submit this new product for FDA approval in Q4 2025.

The 100mm format targets approximately half of the U.S. smoking market and will complement their existing FDA-authorized 84mm king size VLN® cigarettes. The product will be available under the VLN® brand and through partner brands like Smoker Friendly and Pinnacle.

Clinical studies have demonstrated that 22nd Century's proprietary reduced nicotine tobacco helps lower cigarette consumption, increases quit attempts, and reduces cigarette dependence without compensatory smoking behaviors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
20.75%
Tags
none
-
Rhea-AI Summary

22nd Century Group (Nasdaq: XXII) has expanded its Pinnacle brand partnership with a top-5 convenience store chain, launching four new products including two VLN® (low nicotine) cigarette variants and two moist snuff products. The products will be distributed across more than 1,700 stores in 27 states.

The new products include Pinnacle VLN® Gold cigarettes, Pinnacle Menthol VLN® cigarettes, and straight and wintergreen flavored moist snuff. Sales are expected to begin in late summer and early fall 2025, pending state approvals. The agreement also includes potential expansion to other retail and c-store chains.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.6%
Tags
none
Rhea-AI Summary

22nd Century Group (NASDAQ: XXII), a tobacco products company focused on nicotine control solutions, has announced that CEO Larry Firestone will deliver a corporate update presentation at the Emerging Growth Conference on May 21, 2025, at 12:00 PM ET. The presentation will cover recent company developments and include a potential Q&A session.

Investors can submit questions in advance via email and register for the event through the provided webcast link. For those unable to attend live, an archived recording will be available on EmergingGrowth.com and the Emerging Growth YouTube Channel.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.45%
Tags
conferences

FAQ

What is the current stock price of 22Nd Century (XXII)?

The current stock price of 22Nd Century (XXII) is $2.34 as of August 15, 2025.

What is the market cap of 22Nd Century (XXII)?

The market cap of 22Nd Century (XXII) is approximately 917.9K.
22Nd Century

Nasdaq:XXII

XXII Rankings

XXII Stock Data

917.88k
427.30k
14.6%
2.2%
53.65%
Tobacco
Cigarettes
Link
United States
WILLIAMSVILLE